Nevertheless the mortality in sub-Saharan Africa is down 18% since 2005.
Notable successes highlighted in the report include an 18% reduction in child mortality in sub-Saharan Africa, a 9% drop in people living on less than $1.25 a day, a 547% rise in internet users, access to potentially life-saving vaccines for 5.4 million more people, an extra 21 million children in schools and a million fewer new HIV infections.
Results of the fixed effects largely conform to previous studies on child mortality in sub-Saharan Africa.
Despite high levels of under-5 mortality in sub-Saharan Africa, reliable national estimates of causes of death are lacking for most countries.
The World Health Organization estimates that up to 15percentt of the under-five mortality in sub-Saharan Africa is attributable to sickle cell disease.
Malaria and under-nutrition are the two major causes of childhood mortality in sub-Saharan Africa [1].
The association was independent of other metabolic parameters and known risk factors for early ART-associated mortality in sub-Saharan Africa.
To date, there are 4 published studies of the population-level effect of ART roll-out on adult mortality in sub-Saharan Africa[21], [22], [23], [24].
HIV can be transmitted from mother to infant during pregnancy, delivery or postnatally through breastfeeding, and is a major cause of child mortality in sub-Saharan Africa [1].
African trypanosomes cause disease of high morbidity and mortality in sub-Saharan livestock, and it is estimated that controlling the disease would benefit the agricultural industry by US$1300 million per annum [1].
The increased hazard of death conferred by low serum phosphate was independent of other metabolic parameters, hsCRP, and known risk factors for early ART-associated mortality in sub-Saharan Africa, including low BMI, CD4+ lymphocyte count and hemoglobin.
